Eastman Chemical (EMN) Receivables (2009 - 2026)

Eastman Chemical (EMN) has 18 years of Receivables data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 3.34% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 3.34% YoY), and the FY2025 full-year result was $999.0 million, down 14.76% from the prior year.
• Receivables for Q1 2026 stood at $1.2 billion, up from $999.0 million in the prior quarter.
• Across five years, Receivables topped out at $1.6 billion in Q1 2022 and bottomed at $999.0 million in Q4 2025.
• The 5-year median for Receivables is $1.3 billion (2024), against an average of $1.3 billion.
• The widest annual swing landed in 2023, when Receivables fell 27.92%; it then increased 15.93% in 2024.
• A 5-year view of Receivables shows it stood at $1.0 billion in 2022, then advanced by 9.9% to $1.2 billion in 2023, then gained by 1.56% to $1.2 billion in 2024, then declined by 14.76% to $999.0 million in 2025, then rose by 21.82% to $1.2 billion in 2026.
• The last three Receivables figures came in at $1.2 billion (Q1 2026), $999.0 million (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison